Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics
- ACS Med Chem Lett. 2021 Sep 15;12(10):1514-1516. doi: 10.1021/acsmedchemlett.1c00442.
Affiliations
- 1. Usona Institute, 277 Granada Drive, San Luis Obispo, California93401-7337, United States.
PMID: 34676025
DOI: 10.1021/acsmedchemlett.1c00442
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Polo-like Kinase (PLK)Research Areas: Cancer